{"product_id":"getinge-five-forces-analysis","title":"Getinge Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElevate Your Analysis with the Complete Porter's Five Forces Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eGetinge faces moderate supplier power, strong buyer scrutiny, and evolving substitute threats amid intense regulatory and technological pressures—this snapshot highlights key competitive tensions shaping margins and growth prospects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Raw Materials and Components\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge depends on medical-grade alloys and precision electronics that meet MDR\/IVDR standards; roughly 70% of key components come from 6 certified global suppliers, raising supplier leverage. \u003c\/p\u003e\n\u003cp\u003eLimited supplier count means a single disruption can delay production by 4–8 weeks and raise component costs by ~12–18%, squeezing Q4 2024 margins (Getinge reported 2024 adj. EBIT margin 8.9%).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance Costs for Vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSuppliers in medtech must meet ISO 13485 and MDR\/IVDR rules, raising compliance costs often \u0026gt;€1m for certification and audits; that keeps supplier entry low and boosts bargaining power for certified vendors supplying Getinge.\u003c\/p\u003e\n\u003cp\u003eExisting compliant suppliers can command price premiums—industry studies show 5–12% higher margins for certified medtech vendors—while Getinge faces high switching costs from validation timelines of 6–18 months and supplier requalification expenses.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Energy Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge faces high supplier power from logistics and energy volatility because making and shipping bulky sterilizers and OR tables is energy- and freight‑intensive; oil-linked input costs rose ~35% from 2020–2022 and global container rates spiked 7x in 2021–2022, with suppliers often using price‑adjustment clauses to pass inflation to Getinge.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnological Propriety of Components\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge relies on third-party patented components for devices like cardiovascular assist systems, limiting its bargaining power when suppliers hold unique IP; in 2024 Getinge sourced ~12% of procured parts from three specialized suppliers, concentrating risk.\u003c\/p\u003e\n\u003cp\u003eWhen a component is proprietary, price negotiations are weak and switching costs rise—Getinge may face 5–15% higher input costs and longer lead times, tying product margins to supplier pricing. \u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh dependency: ~3 suppliers supply key patented parts\u003c\/li\u003e\n\u003cli\u003eCost impact: proprietary parts add 5–15% to input costs\u003c\/li\u003e\n\u003cli\u003eRisk: supplier concentration = single-point failure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation within the Supply Chain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eConsolidation among medical component manufacturers—driven by deals like Integer\/BD and ConvaTec\/3M moves—has cut vendor counts, boosting supplier market share and bargaining power versus medtech firms such as Getinge.\u003c\/p\u003e\n\u003cp\u003eWith top suppliers now controlling larger slices of supply (estimated 15–25% share increases in key components since 2018), procurement leverage weakens and upward price pressure on inputs rises, squeezing gross margins.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFewer vendors → higher supplier leverage\u003c\/li\u003e\n\u003cli\u003eTop suppliers gained ~15–25% share since 2018\u003c\/li\u003e\n\u003cli\u003eProcurement costs trend upward, margin risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge at Risk: 70% Supply Concentration Threatens Margins as Costs Jump\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh supplier power: ~70% of key components from 6 certified suppliers; supplier disruption delays 4–8 weeks and can raise component costs ~12–18%, squeezing Getinge’s 2024 adj. EBIT margin (8.9%). Certified vendors demand \u0026gt;€1m compliance costs, enabling 5–12% price premiums; switching\/validation takes 6–18 months. Top suppliers gained ~15–25% share since 2018, raising procurement costs.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eKey supplier share\u003c\/td\u003e\n\u003ctd\u003e~70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSuppliers (core)\u003c\/td\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDisruption delay\u003c\/td\u003e\n\u003ctd\u003e4–8 weeks\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCost rise on disruption\u003c\/td\u003e\n\u003ctd\u003e~12–18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCert. cost\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;€1m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrice premium\u003c\/td\u003e\n\u003ctd\u003e5–12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 adj. EBIT\u003c\/td\u003e\n\u003ctd\u003e8.9%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Porter's Five Forces analysis for Getinge that uncovers competitive drivers, supplier and buyer power, substitution risks, and entry barriers, with data-backed insights on threats, strategic positioning, and implications for pricing and profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Porter's Five Forces one-sheet for Getinge—quickly highlights supplier, buyer, and competitive pressures to speed strategic decisions and investor briefings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation of Healthcare Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe rise of large hospital groups and Group Purchasing Organizations (GPOs) has concentrated buying power: in the US the top 10 health systems accounted for ~20% of hospital beds in 2024, and leading GPOs negotiated discounts up to 25–35% on devices, pressuring margins.\u003c\/p\u003e\n\u003cp\u003eThese buyers use scale to secure aggressive pricing and tight service-level agreements; Getinge frequently bids long-term contracts where price transparency is high and replacement cycles are closely specified.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Procurement and Tendering Processes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eA substantial share of Getinge’s 2024 revenue—about 38% of SEK 38.5 billion—comes from government-funded healthcare buyers who use strict public tenders, which are highly price-sensitive and typically award contracts to the lowest bidder meeting minimum specs. This procurement dynamic compresses margins and curbs Getinge’s ability to charge premiums for high-end innovations, especially in markets like the EU where 60% of hospital equipment purchases follow public tenders. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Switching Costs for Integrated Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOnce a hospital installs Getinge’s sterile reprocessing or OR systems, switching costs—installation, staff retraining, validation—can exceed $1–3 million per site and 6–12 months downtime, creating strong lock-in and lowering buyer bargaining power over the equipment lifecycle.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBudgetary Constraints in Public Health\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpmacroeconomic pressures and aging populations have led many national health services to cut capital expenditure oecd spending grew in but budgets tightened pushing hospitals prioritize total cost of ownership roi over features so getinge must prove value via clinical outcomes workflow efficiency win deals.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOECD health spending +3.6% (2024) but CAPEX constrained\u003c\/li\u003e\n\u003cli\u003eCustomers demand ROI, lifecycle costs, and measurable clinical outcomes\u003c\/li\u003e\n\u003cli\u003eGetinge must quantify efficiency gains and patient outcome improvements\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmacroeconomic\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDemand for Value-Based Healthcare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpmodern healthcare buyers are shifting from product sales to value-based contracts that tie payment outcomes pushing getinge absorb operational risk and give more say in device design service kpis about of us hospitals reported active purchasing arrangements up\u003e\n\u003cpsuccess requires deep integration into clinical workflows must embed devices data and service models emr care pathways to meet outcome metrics tightly integrated offerings can reduce readmissions by up in acute pilots.\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eBuyers demand shared-risk contracts, raising bargaining power\u003c\/li\u003e\n\u003cli\u003eClinical integration needed for outcome-linked payments\u003c\/li\u003e\n\u003cli\u003eMarket trend: ~30% US hospitals in value-based deals (2024)\u003c\/li\u003e\n\u003cli\u003eIntegrated solutions can cut readmissions ~15% in pilots\u003c\/li\u003e\n\n\u003c\/psuccess\u003e\u003c\/pmodern\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge under pricing pressure: prove ROI to hold margins amid concentrated buyers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLarge hospital groups, GPOs and public tenders concentrated buying power (top 10 US systems ~20% beds, 2024); price pressure and value-based contracts (≈30% US hospitals, 2024) cut margins, while high switching costs ($1–3M, 6–12 months) create lock-in; Getinge must prove ROI, lifecycle cost and outcomes to retain pricing power.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGetinge revenue share public buyers\u003c\/td\u003e\n\u003ctd\u003e38% of SEK 38.5bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop10 US systems share\u003c\/td\u003e\n\u003ctd\u003e~20% hospital beds\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO discounts\u003c\/td\u003e\n\u003ctd\u003e25–35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue-based deals (US)\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eGetinge Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Getinge Porter's Five Forces analysis you'll receive immediately after purchase—no placeholders, no mockups. The document displayed here is the final, professionally formatted file, ready for download and use the moment you buy. You're viewing the complete deliverable: clear, actionable insights into supplier power, buyer power, competitive rivalry, threat of substitution, and barriers to entry that you can apply right away. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747016126841,"sku":"getinge-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/getinge-five-forces-analysis.png?v=1772194308","url":"https:\/\/growthsharematrix.com\/products\/getinge-five-forces-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}